-+ 0.00%
-+ 0.00%
-+ 0.00%

Acadia Pharmaceuticals signs exclusive Japan distribution deal with KYORIN for DAYBUE STIX

PUBT·11/16/2026 14:06:10
Listen to the news
Acadia Pharmaceuticals signs exclusive Japan distribution deal with KYORIN for DAYBUE STIX
  • Acadia Pharmaceuticals entered an exclusive distribution agreement with KYORIN Pharmaceutical for DAYBUE STIX (trofinetide) in Japan for Rett syndrome.
  • The drugmaker will receive $30 million upfront, with potential regulatory and sales milestone payments and a share of Japanese net sales.
  • KYORIN will lead commercialization and related regulatory activities in Japan on the drugmaker’s behalf.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611160904BIZWIRE_USPR_____20261116_BW895899) on November 16, 2026, and is solely responsible for the information contained therein.